Company profile

ALDOCK company profile

ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer. The company is conducting research and development of risk tests that will help in the early detection of cancer. ALDOCK analyzes biomarker measurement results by machine learning to constantly improve inspection accuracy, and also construct an NGS analysis pipeline for that purpose. It provides a secure API / SDK that can be shared with other applications, as well as the inspection result can be confirmed by the user from the application.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Founded
2016-12-01

Headquarters

Headquarters
Yamanashi, Yamanashi, Japan
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$716.6K
Last funding
Seed / 2019-01-01
Last equity funding
Seed
Investors
2
Lead investors
2
Founders
1

Founders and investors

Founders

Mabuchi Shingo

Lead investors

Incubate FundLifetime Ventures

Investors

Incubate FundLifetime Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.